Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Niels, Kroman"'
Autor:
Frederik Knude Palshof, Lina Steinrud Mørch, Brian Køster, Gerda Engholm, Hans Henrik Storm, Therese M.-L. Andersson, Niels Kroman
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Most Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios of multiple major ri
Externí odkaz:
https://doaj.org/article/9f5568387cf24612a49792808d354e3d
Autor:
Anna L.V. Johansson, Simon M. Kønig, Siri Larønningen, Gerda Engholm, Niels Kroman, Karri Seppä, Nea Malila, Bjarni Á. Steig, Eva Maria Gudmundsdóttir, Elínborg J. Ólafsdóttir, Frida E. Lundberg, Therese M.-L. Andersson, Paul C. Lambert, Mats Lambe, David Pettersson, Bjarte Aagnes, Søren Friis, Hans Storm
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Since the early 2000s, overall and site-specific cancer survival have improved substantially in the Nordic countries. We evaluated whether the improvements have been similar across countries, major cancer types, and age groups. Material
Externí odkaz:
https://doaj.org/article/1d2bd210e5194925b1a7ab5d106cf7d2
Autor:
Anne Katrine Graudal Levinsen, Trille Kristina Kjaer, Thomas Maltesen, Erik Jakobsen, Ismail Gögenur, Michael Borre, Peer Christiansen, Robert Zachariae, Søren Laurberg, Peter Christensen, Niels Kroman, Signe Benzon Larsen, Thea Helene Degett, Lisbet Rosenkrantz Hölmich, Peter de Nully Brown, Christoffer Johansen, Susanne K. Kjær, Lau Caspar Thygesen, Susanne Oksbjerg Dalton
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Many cancer survivors experience late effects after cancer. Comorbidity, health literacy, late effects, and help-seeking behavior may affect healthcare use and may differ among socioeconomic groups. We examined healthcare use amon
Externí odkaz:
https://doaj.org/article/7e82405e058240728d2b43233326c0d5
Autor:
Andreas Werner Nærum, Emil Villiam Holm-Rasmussen, Ilse Vejborg, Ann Søegaard Knoop, Anne-Vibeke Lænkholm, Niels Kroman, Tove Filtenborg Tvedskov
Publikováno v:
The Breast Journal, Vol 2024 (2024)
Background and Purpose. Occult breast cancer (OBC) is a rare condition. Due to the small number of patients in previous studies, the benefits of treatment with mastectomy are still discussed. This study aims to determine the clinicopathological chara
Externí odkaz:
https://doaj.org/article/491d3bca6cef4e79a20134561022aa4c
Autor:
Maria Rossing, Christina Bligaard Pedersen, Tove Tvedskov, Ilse Vejborg, Maj-Lis Talman, Lars Rønn Olsen, Niels Kroman, Finn Cilius Nielsen, Maj-Britt Jensen, Bent Ejlertsen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Axillary lymph node status is an important prognostic factor for breast cancer patients and sentinel lymph node biopsy (SLNB) is a less invasive surgical proxy. We examined if consecutively derived molecular subtypes from primary breast canc
Externí odkaz:
https://doaj.org/article/13c2c9c1e720439e810b95af12a02f1c
Autor:
Malene Martini Clausen, Esben Andreas Carlsen, Camilla Christensen, Jacob Madsen, Malene Brandt-Larsen, Thomas Levin Klausen, Søren Holm, Annika Loft, Anne Kiil Berthelsen, Niels Kroman, Ulrich Knigge, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 851 (2022)
Arginine-Glycine-Aspartate (RGD)-recognizing cell surface integrins are involved in tumor growth, invasiveness/metastases, and angiogenesis, and are therefore an attractive treatment target in cancers. The subtype integrin αvβ3 is upregulated on en
Externí odkaz:
https://doaj.org/article/6b3c40f1d8cb46d9923fd8d511068e66
Autor:
Christina M. S. Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, Niels Kroman, Ann Søegaard Knoop, Tove Holst Filtenborg Tvedskov
Publikováno v:
Breast Cancer Research and Treatment. 198:103-112
The purpose of this study was to examine the effect of chemotherapy on invasive disease-free survival (iDFS) and overall survival (OS) in a nationwide cohort of patients with estrogen receptor (ER)-negative/human epidermal growth factor receptor 2 (H
Autor:
Elsebeth Lynge, Martin Bak, My von Euler-Chelpin, Niels Kroman, Anders Lernevall, Nikolaj Borg Mogensen, Walter Schwartz, Adam Jan Wronecki, Ilse Vejborg
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background In Denmark, national roll-out of a population-based, screening mammography program took place in 2007–2010. We report on outcome of the first four biennial invitation rounds. Methods Data on screening outcome were retrieved from
Externí odkaz:
https://doaj.org/article/416de5148ce847c1aaaa0eac2d1020fe
Autor:
Christina M. S. Hassing, Mathias Kvist Mejdahl, Anne-Vibeke Lænkholm, Niels Kroman, Ann Søegaard Knoop, Tove Holst Filtenborg Tvedskov
Publikováno v:
Breast Cancer Research and Treatment. 196:197-206
The purpose of this study was to evaluate the effect of chemotherapy and trastuzumab on invasive disease-free survival (iDFS) and overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2) positive, T1abN0 breast cancer.In
Autor:
Julie Aarestrup, Britt W. Jensen, Dorthe C. Pedersen, Niels Kroman, Lene Mellemkjær, Jennifer L. Baker, Lise G. Bjerregaard
Publikováno v:
European Journal of Pediatrics. 181:3023-3030